AMEH
Income statement / Annual
Last year (2022), Apollo Medical Holdings, Inc.'s total revenue was $1.14 B,
an increase of 47.84% from the previous year.
In 2022, Apollo Medical Holdings, Inc.'s net income was $45.17 M.
See Apollo Medical Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
01/31/2014 |
| Operating Revenue |
$1.14 B
|
$773.92 M
|
$370.25 M
|
$560.62 M
|
$519.91 M
|
$356.36 M
|
$57.43 M
|
$44.05 M
|
$32.99 M
|
$10.48 M
|
| Cost of Revenue |
$944.69 M |
$596.14 M |
$348.54 M |
$467.81 M |
$361.13 M |
$273.45 M |
$48.74 M |
$34.00 M |
$22.07 M |
$9.08 M |
| Gross Profit |
$199.48 M |
$177.77 M |
$21.71 M |
$92.81 M |
$158.78 M |
$82.90 M |
$8.69 M |
$10.05 M |
$10.92 M |
$1.41 M |
| Gross Profit Ratio |
0.17 |
0.23 |
0.06 |
0.17 |
0.31 |
0.23 |
0.15 |
0.23 |
0.33 |
0.13 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$77.67 M
|
$62.08 M
|
$15.59 M
|
$41.48 M
|
$43.35 M
|
$26.25 M
|
$18.58 M
|
$16.96 M
|
$11.28 M
|
$5.29 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$77.67 M
|
$62.08 M
|
$15.59 M
|
$41.48 M
|
$43.35 M
|
$26.25 M
|
$18.58 M
|
$16.96 M
|
$11.28 M
|
$5.29 M
|
| Other Expenses |
$3.94 M |
-$3.75 M |
$7.69 M |
$3.03 M |
$1.62 M |
$168,102.00 |
$14,701.00 |
$239,057.00 |
$3,031.00 |
$49,702.00 |
| Operating Expenses |
$95.21 M |
$79.59 M |
$15.62 M |
$58.40 M |
$66.55 M |
$45.32 M |
$19.23 M |
$17.31 M |
$11.62 M |
$5.32 M |
| Cost And Expenses |
$1.04 B |
$675.74 M |
$364.16 M |
$526.20 M |
$427.68 M |
$318.78 M |
$67.96 M |
$51.31 M |
$33.68 M |
$14.39 M |
| Interest Income |
$1.98 M |
$1.57 M |
$405,000.00 |
$2.02 M |
$1.26 M |
$1.02 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$7.92 M |
$5.39 M |
$2.53 M |
$4.73 M |
$561,000.00 |
$79,689.00 |
$82,905.00 |
$542,296.00 |
$1.33 M |
$679,184.00 |
| Depreciation &
Amortization |
$29.09 M
|
$11.03 M
|
$25.93 M
|
$18.43 M
|
$19.30 M
|
$19.08 M
|
$351,396.00
|
$351,396.00
|
$334,434.00
|
$31,361.00
|
| EBITDA |
$133.35 M
|
$111.40 M
|
$40.27 M
|
$50.85 M
|
$106.29 M
|
$56.72 M
|
-$9.88 M
|
-$6.68 M
|
-$356,869.00
|
-$3.83 M
|
| EBITDA Ratio |
0.12 |
0.14 |
0.11 |
0.09 |
0.2 |
0.16 |
-0.17 |
-0.15 |
-0.01 |
-0.37 |
| Operating Income Ratio
|
0.09
|
0.13
|
0.02
|
0.06
|
0.17
|
0.1
|
-0.18
|
-0.16
|
-0.02
|
-0.37
|
| Total Other
Income/Expenses Net |
-$17.65 M
|
-$20.43 M
|
$2.78 M
|
-$8.57 M
|
-$9.60 M
|
$14.57 M
|
$1.81 M
|
-$978,297.00
|
-$489,831.00
|
-$629,482.00
|
| Income Before Tax |
$86.62 M |
$77.75 M |
$8.87 M |
$25.84 M |
$82.63 M |
$49.71 M |
-$8.73 M |
-$8.24 M |
-$1.18 M |
-$4.54 M |
| Income Before Tax Ratio
|
0.08
|
0.1
|
0.02
|
0.05
|
0.16
|
0.14
|
-0.15
|
-0.19
|
-0.04
|
-0.43
|
| Income Tax Expense |
$40.88 M |
$31.69 M |
$9.18 M |
$8.17 M |
$22.36 M |
$3.89 M |
-$47,495.00 |
-$71,037.00 |
$163,792.00 |
$19,513.00 |
| Net Income |
$45.17 M |
$68.92 M |
-$23.75 M |
$14.12 M |
$10.84 M |
$25.80 M |
-$8.97 M |
-$9.34 M |
-$1.80 M |
-$5.02 M |
| Net Income Ratio |
0.04 |
0.09 |
-0.06 |
0.03 |
0.02 |
0.07 |
-0.16 |
-0.21 |
-0.05 |
-0.48 |
| EPS |
1 |
1.57 |
-0.65 |
0.41 |
0.33 |
0.8 |
-1.49 |
-1.59 |
-0.37 |
-1.07 |
| EPS Diluted |
0.99 |
1.52 |
-0.63 |
0.39 |
0.29 |
0.8 |
-1.49 |
-1.59 |
-0.37 |
-1.07 |
| Weighted Average Shares
Out |
$44.97 M
|
$43.83 M
|
$36.53 M
|
$34.71 M
|
$32.89 M
|
$32.30 M
|
$6.03 M
|
$5.88 M
|
$4.86 M
|
$4.70 M
|
| Weighted Average Shares
Out Diluted |
$45.60 M
|
$43.83 M
|
$37.45 M
|
$36.40 M
|
$37.91 M
|
$32.30 M
|
$6.03 M
|
$5.88 M
|
$4.86 M
|
$4.70 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
